Literature DB >> 4413338

Evidence for the secretion of an osteoclast stimulating factor in myeloma.

G R Mundy, L G Raisz, R A Cooper, G P Schechter, S E Salmon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4413338     DOI： 10.1056/NEJM197411142912001

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  119 in total

Review 1.  Hypercalcemia of malignancy.

Authors:  V Grill; T J Martin
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Effect of osteoclast activating factor from human leukocytes on bone metabolism.

Authors:  L G Raisz; R A Luben; G R Mundy; J W Dietrich; J E Horton; C L Trummel
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

3.  Multiple myeloma.

Authors:  R M Meyer
Journal:  Can Fam Physician       Date:  1985-06       Impact factor: 3.275

4.  Unusual skeletal metastases from myxoid liposarcoma only detectable by MR imaging.

Authors:  Takahiro Ishii; Takafumi Ueda; Akira Myoui; Noriyuki Tamai; Noboru Hosono; Hideki Yoshikawa
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

5.  Effects of osteoclast activating factor from human lymphocytes on cyclic AMP concentrations in isolated mouse bone and bone cells.

Authors:  R A Luben; M C Chen; D M Rosen; M A Mohler
Journal:  Calcif Tissue Int       Date:  1979-08-24       Impact factor: 4.333

Review 6.  Advances in the understanding of myeloma bone disease and tumour growth.

Authors:  Shmuel Yaccoby
Journal:  Br J Haematol       Date:  2010-03-11       Impact factor: 6.998

7.  Osteosclerotic myeloma variants.

Authors:  F M Hall; S M Gore
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

8.  Editorial: Ectopic secretion by tumours.

Authors: 
Journal:  Br Med J       Date:  1976-05-29

Review 9.  Bone biopsy in haematological disorders.

Authors:  R Burkhardt; B Frisch; R Bartl
Journal:  J Clin Pathol       Date:  1982-03       Impact factor: 3.411

10.  Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo.

Authors:  Claire M Edwards; Seint T Lwin; Jessica A Fowler; Babatunde O Oyajobi; Junling Zhuang; Andreia L Bates; Gregory R Mundy
Journal:  Am J Hematol       Date:  2009-05       Impact factor: 10.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.